Fosamax Cost in Minnesota 2026: What You'll Actually Pay for Alendronate

What Does Alendronate (Fosamax) Cost in Minnesota in 2026?

Generic alendronate 70 mg tablets, taken once weekly, cost approximately $15 per month at most Minnesota retail pharmacies when purchased with a discount card in 2026. Brand-name Fosamax from Merck carries a list price near $80 per month, though actual out-of-pocket costs vary considerably by insurance tier and pharmacy benefit design.

The generic version has been available in the United States since 2008. By 2026, competition among multiple manufacturers has pushed the cash price well below $20 at most Minnesota chains including CVS, Walgreens, Walmart, and Hy-Vee. A 90-day supply of generic alendronate 70 mg (12 tablets, since only one tablet per week is taken) can cost as little as $35 to $40 through GoodRx codes at Costco or Sam's Club pharmacies in Minneapolis and St. Paul metro areas.

Prices quoted at the pharmacy counter without any coupon or insurance are often higher, sometimes reaching $45 to $60 for a 30-day supply of the generic. Always present a discount card before the pharmacist runs the claim. Prices at independent Minnesota pharmacies vary more widely and may be lower in smaller towns where competition with a mail-order pharmacy pushes local pricing down.

Brand Fosamax is rarely the economical choice. The FDA approved alendronate sodium in 1995 for postmenopausal osteoporosis, and the original patent has long since expired [1]. There is no clinical evidence that brand Fosamax performs differently from bioequivalent generics for bone mineral density or fracture outcomes.

The Fracture Intervention Trial (FIT, JAMA 1998, N=2,027) remains the bedrock efficacy data: alendronate reduced the risk of hip fracture by 47% and vertebral fracture by 55% over three years in women with low bone mineral density [2]. That evidence base applies equally to generic alendronate and brand Fosamax.

Minnesota Medicaid (Medical Assistance) Coverage for Alendronate

Minnesota Medicaid, administered as Medical Assistance (MA) through the Minnesota Department of Human Services, covers alendronate with prior authorization (PA). The PA requirement exists because prescribers must document the diagnosis of osteoporosis or a qualifying fracture risk score, not because the drug is considered experimental or unsafe.

A typical PA for alendronate under Minnesota MA requires the following: a confirmed diagnosis of osteoporosis (T-score of -2.5 or below on dual-energy X-ray absorptiometry, or DXA), or documentation of a fragility fracture, or a FRAX 10-year major osteoporotic fracture probability of 20% or higher per National Osteoporosis Foundation guidelines [3]. Most prescribers can complete the PA electronically through the DHS portal within one business day.

Once approved, enrolled MA members typically pay $0 to $3 per prescription under Minnesota's cost-sharing rules for preferred generics. Because alendronate is on the preferred drug list (PDL) for most MA managed care plans operating in Minnesota, including UCare, Blue Plus, and Hennepin Health, the PA approval usually results in coverage at a very low or zero tier-one copay.

Minnesota Health Care Programs (MHCP) also covers alendronate for men diagnosed with osteoporosis and for patients on long-term glucocorticoid therapy (defined as prednisone 7.5 mg or more daily for 90 or more days), consistent with American College of Rheumatology 2022 guidelines on glucocorticoid-induced osteoporosis [4].

Patients whose PA is denied have the right to a formulary exception and a fair-hearing appeal under Minnesota Statute 256B.0625. The HealthRX care team can help prepare PA documentation for telehealth-established patients.

Is Compounded Alendronate Legal in Minnesota?

Yes. A licensed 503A compounding pharmacy in Minnesota may legally prepare customized alendronate formulations for individual patients who have a valid patient-specific prescription from a licensed prescriber. This is distinct from 503B outsourcing facilities, which produce larger batches for healthcare institutions without patient-specific prescriptions.

Under Section 503A of the Federal Food, Drug, and Cosmetic Act, compounded drugs are exempt from FDA new drug approval requirements as long as the preparation is made for an individual patient based on a licensed practitioner's prescription, uses bulk drug substances that appear on the FDA's 503A bulks list or are components of FDA-approved drugs, and is not made in a manner that would be essentially a copy of a commercially available drug [5].

Alendronate sodium is available as an FDA-approved commercial product. Compounding it routinely or in large quantities without a documented clinical reason the commercial product does not meet the patient's needs may draw regulatory scrutiny. Legitimate clinical reasons include swallowing difficulties that make the 70 mg tablet unmanageable, esophageal conditions requiring a liquid formulation, or documented excipient allergies.

The Minnesota Board of Pharmacy oversees 503A compounding facilities within the state. As of 2025, several Minnesota-licensed 503A pharmacies are authorized to prepare alendronate in alternative forms. Patients interested in compounded alendronate should confirm the pharmacy's 503A status with the Minnesota Board of Pharmacy license lookup tool before filling a prescription.

Cost matters here. Some 503A compounding pharmacies offering alendronate in liquid or custom dose form charge $0 to patients whose telehealth visit fee covers the pharmacy cost, or whose insurer covers the compounded formulation under a medical benefit. That $0 price point is specific to programs bundling the compounding fee into a subscription telehealth model, not a standard retail scenario.

HealthRX Compounded vs. Commercial Alendronate Decision Framework (Minnesota)

Use this three-question screen before choosing a compounded alendronate product:

1. Can the patient swallow the standard 70 mg oral tablet and remain upright for 30 minutes afterward? If yes, generic commercial alendronate at $15/month is the appropriate first choice.
2. Does the patient have a documented condition (esophageal stricture, severe GERD, tablet dysphagia) that the commercial tablet cannot accommodate? If yes, a 503A liquid compounded formulation may be clinically indicated. Document this in the chart before sending the prescription.
3. Is the compounding pharmacy currently licensed with the Minnesota Board of Pharmacy as a 503A facility? Confirm before prescribing to avoid dispensing to a non-compliant facility.

How Insurance Covers Alendronate in Minnesota

Most commercial insurance plans sold through the Minnesota individual market on MNsure, as well as large employer group plans, cover generic alendronate at tier 1 or tier 2. At tier 1 (preferred generic), out-of-pocket cost is typically $0 to $15 per 30-day fill or $0 to $40 per 90-day mail-order supply.

Blue Cross and Blue Shield of Minnesota, HealthPartners, Medica, and UCare all list generic alendronate on their standard commercial formularies as of 2025 plan years. These plans do not typically require PA for the generic, though brand Fosamax may require PA and step therapy (demonstrating the generic was tried first) before the brand is covered at any tier.

Medicare Part D, which covers approximately 1.2 million Minnesota residents, covers generic alendronate on nearly every stand-alone Part D plan's formulary [6]. Standard cost-sharing under Part D in 2026 places most generics at $0 to $10 per month during the deductible phase if the plan uses a "deductible-exempt" generic tier, which many Minnesota Part D plans now offer. The $0 copay option for alendronate applies specifically to plans that have placed it on a preferred generic tier with deductible exemption.

The American Association of Clinical Endocrinology 2022 postmenopausal osteoporosis guideline states: "Bisphosphonates remain first-line pharmacologic therapy for most patients at high fracture risk, given their established efficacy, long-term safety data, and low cost" [7]. That low-cost advantage is only realized when patients are using the generic and presenting discount coupons or using insurance correctly.

Minnesota residents on Medicare who remain in a gap-coverage period should note that the Inflation Reduction Act of 2022 restructures Part D cost-sharing beginning in 2025 and 2026, capping out-of-pocket costs at $2,000 annually. Generic alendronate's low price means most patients will not approach that cap on this drug alone.

Telehealth Prescribing of Alendronate in Minnesota

Telehealth prescribing of alendronate is fully legal in Minnesota as of 2025. The Minnesota Telehealth Act (Minnesota Statute 62A.671 through 62A.673) requires that telehealth services meet the same standard of care as in-person services but does not mandate an in-person visit before prescribing [8]. Alendronate is not a controlled substance, so no DEA-related telehealth prescribing restrictions apply.

A telehealth prescriber in Minnesota may initiate alendronate for postmenopausal osteoporosis based on a DXA result the patient has already completed, a clinical history consistent with fragility fracture, or a calculated FRAX score. The prescriber does not need to be physically located in Minnesota, but must hold an active Minnesota medical or advanced practice license.

The standard clinical process via telehealth involves: a video or asynchronous intake visit, review of the patient's most recent DXA (ideally within the last two years), FRAX calculation, assessment for contraindications (estimated glomerular filtration rate below 35 mL/min/1.73m2, hypocalcemia, inability to stand or sit upright for 30 minutes after dosing), and an e-prescription sent to the patient's preferred Minnesota pharmacy.

Alendronate can cause esophageal irritation if not taken correctly. The FDA-approved label specifies: take with 6 to 8 ounces of plain water (not coffee, juice, or mineral water), remain upright for at least 30 minutes, and take at least 30 minutes before the first food or drink of the day [1]. Telehealth providers routinely transmit these instructions through patient portal messaging at the time of prescribing.

The Cheapest Way to Get Alendronate in Minnesota

The single lowest cash price for generic alendronate in Minnesota in 2026 is available through warehouse pharmacies (Costco, Sam's Club) using a GoodRx or RxSaver coupon, typically landing between $12 and $18 for a 30-day supply of the 70 mg weekly tablet. Mark Cuban's Cost Plus Drugs (costplusdrugs.com) lists alendronate sodium 70 mg at approximately $4 to $6 for 4 tablets (a 28-day supply), which may be the lowest price available to any Minnesota resident with a valid prescription and willingness to order through an online pharmacy.

Mail-order through your insurance's preferred pharmacy (Express Scripts, CVS Caremark, or OptumRx, depending on your plan) often provides a 90-day supply at zero or near-zero copay once the deductible is met. For uninsured patients, this mail-order route is not available, making Cost Plus Drugs or GoodRx at a local pharmacy the practical best option.

The National Osteoporosis Foundation reports that fewer than 25% of eligible patients with osteoporosis in the United States receive pharmacologic treatment, and cost is cited as a barrier in a significant proportion of those untreated cases [9]. At $4 to $18 per month for the generic, alendronate is among the most affordable prescription medications in the osteoporosis category compared to denosumab (Prolia), which costs $1,300 to $1,500 per injection every six months, or romosozumab (Evenity), which exceeds $2,000 per monthly injection.

Alendronate Dose, Duration, and What Clinical Data Actually Show

The standard adult dose for postmenopausal osteoporosis is alendronate 70 mg taken orally once weekly, or 10 mg once daily. The weekly formulation produces identical bone mineral density outcomes and has better tolerability compliance because patients take the medication less often [10]. For glucocorticoid-induced osteoporosis, the approved dose is 5 mg daily (or 10 mg daily for postmenopausal women not on estrogen).

The FIT trial (JAMA 1998, N=2,027) remains the most cited efficacy evidence. Over three years, alendronate 5 mg to 10 mg daily reduced hip fracture risk by 47% (relative risk 0.49 to 95% CI 0.23 to 0.99, P<0.05) and clinical vertebral fracture risk by 55% compared to placebo in postmenopausal women with a baseline T-score of -1.6 or below and at least one existing vertebral fracture [2]. Bone mineral density at the lumbar spine increased by 6.2% from baseline in the alendronate group versus a 1.0% increase in the placebo group over 36 months.

Treatment duration is a clinical decision requiring individualization. The American Association of Clinical Endocrinology 2022 guidelines state: "After 5 years of oral bisphosphonate therapy, a drug holiday may be considered in patients at moderate fracture risk, but high-risk patients should generally continue therapy beyond 5 years" [7]. A drug holiday does not mean treatment stops permanently. Reassessment with DXA every two years during a holiday is standard practice.

Atypical femoral fractures are a rare but recognized concern with long-term bisphosphonate use, with an estimated incidence of 3.2 to 50 cases per 100,000 person-years in patients on bisphosphonates for more than five years [11]. Osteonecrosis of the jaw is extremely rare in patients taking oral alendronate for osteoporosis (versus higher doses used in oncology). Routine dental care does not require stopping alendronate.

Minnesota-Specific Resources and Next Steps

Minnesota residents seeking alendronate have several state-level resources beyond the standard retail pharmacy. The Minnesota Department of Human Services pharmacy benefit line (651-431-2600) can confirm MA prior authorization status for a specific patient. The Minnesota Board of Pharmacy website (mn.gov/boards/pharmacy) lists all licensed 503A compounding pharmacies operating in the state.

The University of Minnesota Medical Center and Mayo Clinic Rochester both operate dedicated bone health and osteoporosis clinics where DXA scanning and fracture risk assessment are available. DEXA referrals from telehealth prescribers are processed by both institutions for Minnesota patients, typically with a two-to-four-week scheduling window.

Patients who have not had a DXA within the past two years should request one before starting alendronate. The U.S. Preventive Services Task Force recommends osteoporosis screening with bone measurement testing for women 65 and older, and for younger postmenopausal women whose 10-year fracture risk is equal to or greater than that of a 65-year-old white woman with no additional risk factors [12].

A telehealth prescriber can order a DXA at a Minnesota outpatient radiology facility and review results before sending the alendronate prescription. The entire process, from telehealth intake visit to pharmacy pickup, can be completed in three to five business days in most Minnesota metro areas and seven to ten business days in rural counties where radiology scheduling takes longer.

Generic alendronate 70 mg costs approximately $15 per month at most Minnesota pharmacies in 2026. Present a GoodRx or RxSaver coupon at the pharmacy counter every time, because insurance adjudication at the wrong tier can cost more than the coupon price.